Department of Immunology
K. Jagannadha Sastry has not added Biography.
If you are K. Jagannadha Sastry and would like to personalize this page please email our Author Liaison for assistance.
A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
Antiviral research Dec, 2002 | Pubmed ID: 12406507
Flow cytometric analysis of macaque whole blood for antigen-specific intracellular cytokine production by T lymphocytes.
Journal of medical primatology Feb, 2003 | Pubmed ID: 12733599
Dendritic cells enhance detection of antigen-specific cellular immune responses by lymphocytes from rhesus macaques immunized with an HIV envelope peptide cocktail vaccine.
Journal of medical primatology Apr, 2003 | Pubmed ID: 12823628
SHIV transmission and susceptibility to re-exposure through social contact following vaccination with an HIV synthetic peptide-cocktail: a case study.
Journal of medical primatology Feb, 2004 | Pubmed ID: 15061727
A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
Vaccine Dec, 2004 | Pubmed ID: 15530705
Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
Vaccine Mar, 2005 | Pubmed ID: 15755586
Improving the sensitivity of the ELISPOT analyses of antigen-specific cellular immune responses in rhesus macaques.
Methods in molecular biology (Clifton, N.J.) , 2005 | Pubmed ID: 15937350
Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
Gynecologic oncology Dec, 2005 | Pubmed ID: 16188303
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.
Journal of virology Mar, 2006 | Pubmed ID: 16501119
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection.
Vaccine Apr, 2007 | Pubmed ID: 17291642
Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail.
Virology Jan, 2008 | Pubmed ID: 17920095
Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.
Vaccine Dec, 2007 | Pubmed ID: 18063450
Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.
Journal of virology Sep, 2008 | Pubmed ID: 18596086
Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.
Cancer research Jul, 2008 | Pubmed ID: 18632641
Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens.
Vaccine May, 2009 | Pubmed ID: 19200849
Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines.
PloS one , 2009 | Pubmed ID: 19333387
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells.
Proceedings of the National Academy of Sciences of the United States of America Sep, 2009 | Pubmed ID: 19805372
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines.
Viruses Dec, 2009 | Pubmed ID: 20107521
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans.
Virology Oct, 2010 | Pubmed ID: 20667573
Functional impairment of central memory CD4 T cells is a potential early prognostic marker for changing viral load in SHIV-infected rhesus macaques.
PloS one , 2011 | Pubmed ID: 21602924
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten